Healthcare -
Biotechnology - NASDAQ - US
$ 690.89
-1.12 %
$ 74.3 B
Market Cap
18.01
P/E
REGN - COMMON STOCK REPURCHASED
Common Stock Repurchased REGN - Regeneron Pharmaceuticals, Inc.
-3.63 B
LAST VALUE
-19.86%
2 YEAR CAGR
-50.92%
5 YEAR CAGR
-29.80%
10 YEAR CAGR